Effect of immunosuppressive treatment protocol on malignancy development in renal transplant patients.
Haberal
M
M
Baskent University Faculty of Medicine, Ankara, Turkey. melekk@baskent-ank.edu.tr
Moray
G
G
Karakayali
H
H
Emiroğlu
R
R
Başaran
O
O
Sevmiş
S
S
Demirhan
B
B
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000401:mortality / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000145:classification / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
D007166:Immunosuppressive Agents